Clinical usefulness of (18)F-FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis.

Fiche publication

Date publication

avril 2017

Journal

Nuclear medicine and biology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MEYER Nicolas , Pr IMPERIALE Alessio

Tous les auteurs :
Lefebvre N, Argemi X, Meyer N, Mootien J, Douiri N, Sferrazza-Mandala S, Schramm F, Weingertner N, Christmann D, Hansmann Y, Imperiale A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28426991

Résumé

Few studies have evaluated the promising role of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (PET) and PET/computed tomography FDG PET/CT in evaluating and monitoring treatment response in patients with lymph node tuberculosis (LNTB). The aim of this clinical investigation was to assess the clinical usefulness of FDG PET/CT for initial tuberculosis staging and to determine the prognostic value of the decrease of (18)F-FDG uptake during antibiotic treatment in LNTB patients.